NeoStem, Inc. is an international biopharmaceutical company with adult stem cell operations in the U.S., a network of adult stem cell therapeutic providers in China as well as a 51% ownership interest in a profitable Chinese generic pharmaceutical manufacturing company. NeoStem is focused on accelerating the development of proprietary cellular therapies and becoming a single source for collection, storage, manufacturing, therapeutic development and transportation of cells for cell based medicine and regenerative science globally.  The Company also has licensed various cellular therapy technologies, including worldwide exclusive licenses to a wound healing technology and to VSEL™ Technology which uses very small embryonic-like stem cells, which are adult stem cells that have been shown to have several physical characteristics that are generally found in embryonic stem cells.

For more information on NeoStem, click here.

A member of the NeoStem group of companies

As a member of the  NeoStem group of companies, NeoStem Family Stem Cell Banking is uniquely positioned to leverage internal scientific, laboratory,  and clinical expertise to the benefit of its partners and clientele.

NeoStem Family Stem Cell Banking is a wholly-owned subsidiary of Progenitor Cell Therapy, LLC, a NeoStem company (www.progenitorcelltherapy.com). Founded in 1997 by medical and scientific leaders in the cell therapy field, Progenitor Cell Therapy, also known as PCT, has become the leading provider of cell therapy support services to its client companies worldwide from its state-of-the-art clean room facilities and laboratories in the United States.  Headquartered in New Jersey, with operations in California, PCT has performed over 32,000 cell-based procedures since its operations began. An ever-increasing roster of cell therapy companies and leading stem cell transplantation programs rely on PCT.

Each parent choosing NeoStem to collect and store their baby’s cord blood stem cells can share in the same confidence as expressed in PCT by its institutional investors and some of the world’s foremost cell therapy companies which entrust the development of their products to PCT.

Building Collection Partners

In addition to providing cord blood collection and banking services direct to parents, NeoStem also partners with hospitals and physicians to offer a turnkey cord blood banking program that assures the highest quality and ease of use to participating partners.

By partnering with leading hospitals and physicians, NeoStem provides its collection partner programs and stem cell banking clientele with the benefits gained from having a common national infrastructure and shared protocols.

The NeoStem partnership allows participating collection programs to quickly translate the latest cutting-edge scientific and clinical developments into ongoing program improvements focused on ensuring the stem cells collected and stored are of the highest quality and are available for use in the latest therapeutic applications.